BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23075170)

  • 1. Acid-labile Cys-protecting groups for the Fmoc/tBu strategy: filling the gap.
    Góngora-Benítez M; Mendive-Tapia L; Ramos-Tomillero I; Breman AC; Tulla-Puche J; Albericio F
    Org Lett; 2012 Nov; 14(21):5472-5. PubMed ID: 23075170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrahydropyranyl, a nonaromatic acid-labile Cys protecting group for Fmoc peptide chemistry.
    Ramos-Tomillero I; Rodríguez H; Albericio F
    Org Lett; 2015 Apr; 17(7):1680-3. PubMed ID: 25764355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The investigation of Fmoc-cysteine derivatives in solid phase peptide synthesis.
    McCurdy SN
    Pept Res; 1989; 2(1):147-52. PubMed ID: 2577698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Methoxybenzyloxymethyl group, a racemization-resistant protecting group for cysteine in Fmoc solid phase peptide synthesis.
    Hibino H; Nishiuchi Y
    Org Lett; 2012 Apr; 14(7):1926-9. PubMed ID: 22452360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of protected peptidyl thioester intermediates for native chemical ligation by Nalpha-9-fluorenylmethoxycarbonyl (Fmoc) chemistry: considerations of side-chain and backbone anchoring strategies, and compatible protection for N-terminal cysteine.
    Gross CM; Lelièvre D; Woodward CK; Barany G
    J Pept Res; 2005 Mar; 65(3):395-410. PubMed ID: 15787970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-->O-Acyl shift in Fmoc-based synthesis of phosphopeptides.
    Eberhard H; Seitz O
    Org Biomol Chem; 2008 Apr; 6(8):1349-55. PubMed ID: 18385841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of the very acid-sensitive Fmoc-Cys(Mmt)-OH and its application in solid-phase peptide synthesis.
    Barlos K; Gatos D; Hatzi O; Koch N; Koutsogianni S
    Int J Pept Protein Res; 1996 Mar; 47(3):148-53. PubMed ID: 8740963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fmoc/Trt-amino acids: comparison to Fmoc/tBu-amino acids in peptide synthesis.
    Barlos K; Gatos D; Koutsogianni S
    J Pept Res; 1998 Mar; 51(3):194-200. PubMed ID: 9531422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side reactions in the SPPS of Cys-containing peptides.
    Stathopoulos P; Papas S; Pappas C; Mousis V; Sayyad N; Theodorou V; Tzakos AG; Tsikaris V
    Amino Acids; 2013 May; 44(5):1357-63. PubMed ID: 23459989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fmoc solid-phase synthesis of cyclopeptide FIK].
    Zhang J; Shi W; Chen W
    Sheng Wu Gong Cheng Xue Bao; 2008 Mar; 24(3):468-72. PubMed ID: 18589824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regioselective formation of the three disulfide bonds of a 35-residue insect peptide.
    Kellenberger C; Hietter H; Luu B
    Pept Res; 1995; 8(6):321-7. PubMed ID: 8838415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated peptides I: Solid-phase synthesis of N alpha-pegylated peptides using Fmoc strategy.
    Lu YA; Felix AM
    Pept Res; 1993; 6(3):140-6. PubMed ID: 8318745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Edman degradation sequence analysis of resin-bound peptides synthesized by 9-fluorenylmethoxycarbonyl chemistry.
    Fields CG; VanDrisse VL; Fields GB
    Pept Res; 1993; 6(1):39-47. PubMed ID: 8439735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine-S-trityl a key derivative to prepare N-methyl cysteines.
    Marcucci E; Bayó-Puxan N; Tulla-Puche J; Spengler J; Albericio F
    J Comb Chem; 2008; 10(1):69-78. PubMed ID: 18020422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated Fmoc-based solid-phase synthesis of peptide thioesters with self-purification effect and application in the construction of immobilized SH3 domains.
    Mende F; Beisswenger M; Seitz O
    J Am Chem Soc; 2010 Aug; 132(32):11110-8. PubMed ID: 20662535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New t-butyl based aspartate protecting groups preventing aspartimide formation in Fmoc SPPS.
    Behrendt R; Huber S; Martí R; White P
    J Pept Sci; 2015 Aug; 21(8):680-7. PubMed ID: 26077723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete TFA deprotection of N-terminal trityl-asparagine residue in fmoc solid-phase peptide chemistry.
    Friede M; Denery S; Neimark J; Kieffer S; Gausepohl H; Briand JP
    Pept Res; 1992; 5(3):145-7. PubMed ID: 1421802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-(N-Fmoc)-3-(N-Boc-N-methoxy)-diaminopropanoic acid, an amino acid for the synthesis of mimics of O-linked glycopeptides.
    Carrasco MR; Brown RT; Doan VH; Kandel SM; Lee FC
    Biopolymers; 2006; 84(4):414-20. PubMed ID: 16508952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Handles for Fmoc solid-phase synthesis of protected peptides.
    Góngora-Benítez M; Tulla-Puche J; Albericio F
    ACS Comb Sci; 2013 May; 15(5):217-28. PubMed ID: 23573835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the excluded protecting group (EPG) method for peptide synthesis.
    Head DB; Dong JZ; Burton JA
    J Pept Res; 2005 Mar; 65(3):384-94. PubMed ID: 15787969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.